Monitor for any future amendments that could indicate a shift from passive to active intent, or further accumulation. The stake is just above the 5% threshold, so the filing itself is routine.
ALXO drugs
ALXO drug pipeline →Price Chart
How similar events traded
Executive Summary
Coastlands Capital LP disclosed a 5.34% passive stake in ALX Oncology Holdings Inc., holding 6,906,783 shares as of November 12, 2026. This is a new 13G filing (not an amendment) from a healthcare-focused investment firm, indicating a meaningful but passive position in the company.
Key Financial Metrics
Key Facts
- Coastlands Capital LP filed a new Schedule 13G disclosing beneficial ownership of 6,906,783 shares of ALX Oncology Holdings Inc.
- The stake represents 5.34% of the 129,274,568 shares outstanding as of November 9, 2026.
- The shares are held directly by Coastlands Capital Partners LP, with Coastlands Capital LP as investment adviser.
- The filing certifies passive intent under Rule 13d-1(b) and Rule 13d-1(c), with no purpose of changing or influencing control.
- Matthew D. Perry is the control person of the reporting entities.
Financial Impact
6,906,783 shares, representing 5.34% of outstanding shares, valued at approximately $6.9M based on market cap of $130M.
Risk Factors
- No risks identified from this passive stake filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0001104659-26-130295 |
| Document: 0001104659-26-130295-index-headers.html | 0001104659-26-130295 |
| Document: 0001104659-26-130295-index.html | 0001104659-26-130295 |
| Document: 0001104659-26-130295.txt | 0001104659-26-130295 |
Track record
17 reports on ALXO
3 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +25.96% at T+20 after the May 8, 2026 report. 3 of 4 went positive at some point.
Filters
- Nov 19, 20262d ago SC 13G Neutral 4/10 Viewing Entry $0.9714 Now $1.06 +9.12% settles Nov 30
- Nov 16, 20265d ago Press Release Bearish 5/10 Entry $1.00 Now $1.06 −6.00% settles Nov 23
- Oct 16, 20265w ago SC 13D/A Neutral 4/10 Entry $1.14 to $1.13 Now $1.06 −7.02% ▼ −0.88% −0.73% vs SPY
- Oct 15, 20265w ago 8-K Mixed 6/10 Entry $1.06 to $1.17 Now $1.06 −0.00% ▲ +10.38% +10.81% vs SPY
- Sep 28, 20267w ago Press Release Mixed 5/10 Entry $1.39 to $1.21 Now $1.06 −23.74% ▼ −12.95% −14.15% vs SPY
- Aug 15, 202614w ago Institutional Cluster Neutral 4/10 Entry $1.97 to $1.99 Now $1.06 −46.19% ▲ +1.02% +2.21% vs SPY
- Aug 6, 202615w ago 8-K Neutral 4/10 Entry $2.11 to $1.94 Now $1.06 −49.76% ▼ −8.06% −9.27% vs SPY
- Jun 30, 202620w ago 8-K Neutral 3/10 Entry $2.06 to $2.36 Now $1.06 −48.54% ▲ +14.56% +14.30% vs SPY
- Jun 26, 202621w ago 8-K Neutral 5/10 Entry $2.20 to $2.19 Now $1.06 −51.82% ▼ −0.45% −1.84% vs SPY
- Jun 12, 202623w ago Institutional Cluster Bearish 5/10 Entry $1.58 to $1.53 Now $1.06 +32.91% ▲ +3.16% +3.84% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers